Get started
Mankind Pharma Ltd.Mankind Pharma Ltd.Mankind Pharma Ltd.

Mankind Pharma Ltd.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsOptionsBondsETFs

MANKIND trade ideas

MANKIND Pharma Ready to blastNSE:MANKIND Nice breakout, with volume surges. Now trying to retest Support. Good to keep on the radar Always respect SL & position sizing ======================== Trade Secrets By Pratik ======================== Disclaimer NOT SEBI REGISTERED This is our personal view and this analysis is only for educational purposes Please consult your advisor before investing or trading You are solely responsible for any decisions you take on basis of our research.
NSE:MANKINDLong
by Trade_Secrets_By_Pratik
Mankind Pharma cmp 2578.30 by a Weekly Chart view since listedMankind Pharma cmp 2578.30 by a Weekly Chart view since listed - Support Zone 2400 to 2500 Price Band - Resistance Zone 2675 to 2785 Price Band - Symmetrical Triangle Breakout well sustained - Back to back Bullish Rounding Bottom with Resistance Zone neckline - Most common Technical Indicators BB, EMA, SAR, MACD, RSI turning positive - Good Volumes increase, well above avg traded quantity by demand based buying - Rising Price Channel well respected basis testing retesting by upside price momentum
NSE:MANKIND
by PIYUSHCHAVDA
MANKIND PHARMA – Descending Triangle Breakout________________________________________________________________________________📈 MANKIND PHARMA – Falling Trendline Breakout | Strong Reversal Candle | Volume Spike 🕒 Chart Type: Daily Chart 📆 Date: July 9, 2025 ________________________________________________________________________________ 📌 Price Action: MANKIND PHARMA has executed a decisive breakout above a falling trendline on the daily chart, breaking out of a multi-week descending structure. The price action had been consolidating within a triangular pattern, and on July 9, it registered a powerful wide-range bullish candle, closing at 2526.60 — well above the recent consolidation highs. This move came from a structured base with two strong pivot lows and now places the stock back into a strong bullish trajectory. The breakout is not random; it’s backed by structure, momentum, and confirmation — suggesting potential for a trend continuation if sustained. ________________________________________________________________________________ 📊 Chart Pattern: The chart shows a descending triangle breakout with compression near the apex. This setup builds pressure and usually resolves in the direction of volume. The move out of this pattern has occurred with authority, marked by a clean range expansion and bullish follow-through above resistance. This is a momentum-confirming breakout, which opens up room toward testing higher resistance zones. ________________________________________________________________________________ 🕯️ Candlestick Pattern: Strong Bullish Candle Open = Low (Intraday strength) Buy Today, Sell Tomorrow-type price action Aligned with Volume Spike and Trendline Breakout ________________________________________________________________________________ 🔊 Volume Analysis: The breakout is accompanied by more than 2x the 20-day average volume, signaling real participation — not just speculative noise. Delivery volumes are notably strong, and volume came after a phase of tight consolidation, which indicates a possible transition from quiet accumulation to active participation by stronger hands. ________________________________________________________________________________ 📈 Technical Indicators: RSI (Daily): 66 – strong, trending up MACD: Bullish crossover, both on Daily and Weekly CCI: 220 – highly bullish momentum territory Stochastic: 94 – overbought but confirming momentum SuperTrend & VWAP: Clearly bullish Bollinger Band: Price is expanding beyond upper band — volatility expansion in motion ________________________________________________________________________________ 🧱 Support & Resistance: 🔻 Supports: 2448.27 – Immediate support (previous breakout zone) 2369.93 – Structure base support 2322.27 – Last defense before breakout invalidation Bottom Range / Demand Zone: 2115.1 – Long-term accumulation zone 🔺 Resistance Zones: 2574.27 – First supply zone; watch for price reaction 2621.93 – Medium-term resistance; previously rejected here 2700.27 – Higher timeframe swing resistance Top Range: 2998.4 – Long-term resistance; breakout confirmation if crossed ________________________________________________________________________________ 👀 What’s Catching Our Eye: What stands out is the confluence breakout — trendline, structure, volume, and indicators are all pointing in the same direction. The BB squeeze, RSI breakout, and strong candle together make this a multi-signal setup — rarely do we get such alignment across tools. ________________________________________________________________________________ 🔍 What We’re Watching For: Will the price hold above 2448–2526 for the next couple of sessions? If yes, this breakout can see momentum continuation toward 2574+. Any low-volume pullback toward the trendline or support zone could be a low-risk re-entry. If it fails to hold above the breakout candle, momentum could fade. ________________________________________________________________________________ ✅ Best Buy Level for Equity (Low Risk Idea): Entry: Above 2543.60 (post-breakout confirmation or clean retest of 2448–2455 zone) Stop Loss: 2404.95 (on a closing basis) Risk Reward Strategy: 1:1 initially, trail for 1:2+ if volume expands Avoid chasing: Let the price validate with sustained volume above breakout ________________________________________________________________________________ 💼 Sector Tailwinds: The pharmaceutical sector is seeing renewed investor interest post-COVID, with growing focus on specialty products, chronic therapy lines, and export-led growth. MANKIND is among the strongest consumer-pharma brands with consistent results and brand recall — adding fundamental strength to this technical breakout. ________________________________________________________________________________ ⚠️ Risk to Watch: A close below 2448 could invalidate this setup The overbought Stochastic means minor pullbacks or shakeouts are possible Don’t chase — always confirm the breakout with a retest or follow-through candle Over-positioning during volatility can lead to poor R:R trades ________________________________________________________________________________ 🔮 What to Expect Next: If this breakout holds, we may see follow-through toward 2574.27 in the short term. Strong volume above 2540+ can unlock upside toward 2621+. However, if the price closes below 2448, we may be dealing with a failed breakout — a scenario to strictly avoid. Watch next 2–3 sessions for clarity. ________________________________________________________________________________ 🧠 How to Trade MANKIND PHARMA (For Educational Use Only): 🔹 Breakout Trade Plan Entry: Above 2543.60 Stop Loss: 2404.95 (Closing basis) Pullback Entry: Into 2448 zone with bounce candle Risk-Reward: Start with 1:1, then trail to 1:2+ Position Sizing: Risk-calibrated, never go all-in ________________________________________________________________________________ ⚠️ Disclaimer (Please Read): • This chart is shared for educational purposes only and is not investment advice. • I am not a SEBI-registered advisor. • The information provided here is based on personal market observation. • No buy/sell recommendations are being made. • Please do your own research or consult a registered financial advisor before making any trading decisions. • Trading involves risk. Always use proper risk management. ________________________________________________________________________________ 💬 Found this helpful? What’s your ideal approach to this setup — breakout entry or pullback into zone? Drop your thoughts or questions in the comments below ⬇️ 🔁 Share this post with your trading community ✅ Follow STWP for clean technical setups backed by price action and volume 🚀 Let’s trade with patience, logic, and clarity! Be Self-Reliant | Trade with Patience | Learn with Logic ________________________________________________________________________________
NSE:MANKINDLong
by simpletradewithpatience
Mankind Pharma Ltd (MANKIND)Mankind Pharma’s revolves around developing, manufacturing, and marketing affordable, high-quality pharmaceutical and consumer healthcare products, with a focus on accessibility and scale. Product Portfolio: Offers a diverse range of generics, branded generics, and specialty drugs across therapeutic areas like anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, dermatology , and respiratory . Consumer healthcare products include condoms (Manforce) , pregnancy test kits (Prega News) , and emergency contraceptives (Unwanted-72) , contributing significantly to revenue. Market Strategy: Strong domestic presence, with India accounting for ~80% of revenue; exports to 34 countries in Asia, Africa, and the Middle East. Strategic acquisitions, like Bharat Serums and Vaccines (2024, ₹13,630 crore), expand high-margin segments like women’s health and fertility. Revenue Model: Primarily B2B (business-to-business) through sales to distributors and pharmacies, supplemented by direct-to-consumer OTC products. Revenue for FY25: ₹12,207 crore, with a profit of ₹2,011 crore, driven by high-volume, low-cost generics and growing consumer healthcare sales. Sustainability and Scale: Emphasizes scalable operations with low-cost production and a lean supply chain. Invests in sustainability initiatives and community health programs to enhance brand trust. This model combines volume-driven generics, strategic innovation, and aggressive market outreach to maintain Mankind’s position as India’s fourth-largest pharma company by sales. Affordability and Accessibility: Focuses on price-disruptive generics, targeting cost-conscious markets, especially rural and semi-urban India. Leverages a vast distribution network of over 16,000 stockists and 10,000+ field staff to ensure deep market penetration. Manufacturing and R&D: Operates 30 manufacturing facilities in India, with USFDA-approved plants for regulated markets. Six R&D centers drive innovation, developing complex generics and specialty drugs like Dydrogesterone (Dydroboon). Backward integration ensures cost efficiency and quality control.
NSE:MANKIND
by askbiswanath2025
Mankind Pharma - Breakout out of Falling Wedge PatternMankind Pharma is one of the 4 largest Pharma from domestic market perspective. It has fallen 30% from peak price, but has recently given BO from fallen wedge pattern. This looks a great stock: 1. 4 brands are having top market share and growing 2. First Co. to make oral anti-obesity medicine 3. Acquisition of BSV has made a very strong hold in women healthcare 4. Best YoY results with rising EPS Technically also, Pharma sector looking strong and especially top 5 Indian Pharma Industry companies which includes Mankind Pharma. Keep this in your radar. Keep following @Cleaneasycharts as we prvoide Right Stock at Right Time at Right Price!! Cheers!!
NSE:MANKINDLong
by Cleaneasycharts
1
Mankind Pharma: Fundamental & Technical Analysis for TradersFinancial Performance Overview Mankind Pharma, a leading player in the pharmaceutical sector, recently released its Q3 financial results for the period ending December 31, 2024. The company reported a 16.5% decline in net profit, falling to ₹384 crore from ₹460 crore in the same quarter last year. This decline was primarily due to increased expenses, including costs related to the acquisition of Bharat Serums and Vaccines in October 2024. Despite the profit decline, the company saw a strong revenue growth of 24%, with revenue from operations rising to ₹3,230 crore from ₹2,607 crore year-over-year. This surge is largely driven by an increased market share in chronic illness drugs, which grew to 37.6% from 35.6%. The company's market capitalization stands at ₹99,640 crore, with a P/E ratio of 45.16. Technical Analysis & Trading Outlook Current Market Price (CMP): ₹2,415.05 Chart Pattern: The stock recently formed a falling wedge pattern on the daily time frame (TF) and gave a breakout with a significant volume increase of 2.36M. Breakout Confirmation: If the price closes above ₹2,442, we can expect a strong bullish move. Upside Targets Post-Breakout: Short-term Target: ₹2,610 Medium-term Target: ₹2,750 Long-term Target: ₹3,002 Potential Downside & Reversal Zone If the price experiences a pullback, we can expect a reversal zone between ₹2,253 - ₹2,336. A bounce from this level could trigger bullish momentum, offering an ideal re-entry point for traders. With strong revenue growth, technical breakout confirmation, and a well-defined support zone, Mankind Pharma remains a stock to watch for both fundamental investors and technical traders. Disclaimer: This analysis is for educational purposes only. Investors should conduct their own research before making any trading decisions.
NSE:MANKIND
by ALICEBLUE
MANKIND PHARMA : Trending Stock#MANKIND #swingtrading #breakout #trendingsetup #momentumtrade MANKIND : Swing Trade >> Trending setup >> Breakout & Retest done >> Momentum Trade setup >> Good Strength & Volume Dry Setup >> Low Risk High Reward Trade Swing Traders can lock profit at 10% and keep trailing Pls Boost, follow & Comment for more Learnings Disc : Charts shared are for Learning purpose, not a trade recommendation. Consult your financial advisor and do your own research before buying
NSE:MANKINDLong
by moneyfesttrading
Near & Clean Breakout seen in Mankind Pharma Greetings to all. I trust that you are all well. Today, I would like to present a stock that has recently experienced a clear and significant breakout, and it is currently trading above the breakout levels. This stock possesses the potential to yield returns in the range of 15% to 19% in the near term, making it an excellent candidate for a positional trade. I have meticulously marked all relevant levels on the accompanying chart. This stock is characterized by its aggressive nature, indicating a high probability of achieving a 15% momentum in a very short timeframe. Disclaimer:- It is essential to conduct your own analysis or seek advice from a financial advisor prior to engaging in any trading activities. Dear traders, if you appreciate my contributions, kindly show your support by liking and following my work. I welcome your thoughts on this idea in the comments section and would be pleased to respond to each of you. Thank you.
NSE:MANKINDLong
by TraderRahulPal
2
Mankind Pharma Ltd - Cup with handle pattern formationThe cup with handle pattern is a bullish chart formation resembling a cup with a slight consolidation (handle) on the right. A trading strategy involves entering a position when the price breaks above the resistance level at the top of the cup, ideally after confirming bullish momentum. Mankind Pharma is forming a cup with handle pattern on the hourly timeframe, signaling potential bullish movement. The handle has formed on a flat base, reinforcing the bullish setup. Where the prior resistance become support (Support-Resistance Flip). Chart Structure: Price is creating higher tops and higher bottoms, indicating a strong uptrend where as RSI is trending higher and remains above 50, confirming positive momentum. Trade execution planned above 2835,anticipated target is above 3000, suggesting substantial upside potential if the breakout is confirmed. SL would be the last higher swing low.
NSE:MANKINDLong
by Arvind_Share_Academy
MANKIND -Flag and Pole -Daily - Breakout **Mankind Pharma Ltd.** shows a clear **flag and pole pattern**, indicating a potential continuation of the uptrend. Here's a breakdown of the technical analysis: ### Key Observations: 1. **Flag and Pole Pattern**: - The pattern consists of a sharp upward movement (the pole) followed by a consolidation phase (the flag), forming between parallel lines. - The breakout above the flag pattern suggests a bullish continuation, with a price target typically equal to the length of the pole added to the breakout point. 2. **Target Price**: - The length of the pole is measured at **660.85 points (34.81%)**, and applying this to the breakout level a target near **3,217 INR**, as marked on the chart. 3. **Volume Confirmation**: - The breakout has been accompanied by an increase in volume, confirming the validity of the upward movement. - Higher-than-average volume during breakouts adds credibility to the bullish scenario. 4. **Support Levels**: - Near-term support lies at **2,559 INR**, followed by a stronger support zone around **2,372 INR** if there’s a pullback. 5. **Resistance Levels**: - Immediate resistance is expected near **2,665 INR** (recent high), with the next target at the calculated level of **3,217 INR** based on the flag and pole projection. ### Conclusion: This chart suggests a bullish outlook for **Mankind Pharma Ltd.**, with potential for further upside as the flag and pole pattern points to a target of around **3,217 INR**. Traders may want to watch for price action around current resistance levels and ensure volume continues to support the move. Would you like any further analysis on this?
NSE:MANKINDLong
by DailyCharts03
Buy Mankind Pharma for major upside . 2 lakh to 2 Cr journey Cmp 2300 Buy near 2280 short term target 2408 &2495 Now take a look of Long term journey Mankind Pharma cam be a multibagger counter 5 years Sales, profit and return of equity growth almost more than 20% and this can be increase more and more . Counter going to reach at 1 lakh cr capital this year and after that it will unstoppable . 100% debt free company All the parameter are perfect for long term selection . Just invest 2 lakh in this counter during upcoming 2 years and sleep relax... After 20 years your 2 lakh will become 2 cr. We personally start investing in this counter . If you dont have 2 lakh then you can follow 5000Rs SIP for 40 months You can earn with trading but if you want to create a wealth then long term investing is only solution . Dont miss this opportunity .
NSE:MANKINDLong
by MVLINDIA